Background-Klotho-knockout mice (klotho Ϫ/Ϫ ) have increased renal expression of sodium/phosphate cotransporters (NaPi2a), associated with severe hyperphosphatemia. Such serum biochemical changes in klotho Ϫ/Ϫ mice lead to extensive soft-tissue anomalies and vascular calcification. To determine the significance of increased renal expression of the NaPi2a protein and concomitant hyperphosphatemia and vascular calcification in klotho Ϫ/Ϫ mice, we generated klotho and NaPi2a double-knockout (klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ ) mice. Methods and Results-Genetic inactivation of NaPi2a activity from klotho Ϫ/Ϫ mice reversed the severe hyperphosphatemia to mild hypophosphatemia or normophosphatemia. Importantly, despite significantly higher serum calcium and 1,25-dihydroxyvitamin D levels in klotho
U nderstanding the molecular regulation of phosphate homeostasis has enormous clinical and biological importance because it is involved in numerous essential biochemical reactions, including cell signaling process and energy metabolism. Adequate bone mineralization is closely dependent on the status of phosphate metabolism. Abnormal regulation of phosphate homeostasis can cause myopathy, cardiac dysfunctions, hematologic abnormalities, and vascular and soft-tissue calcifications. [1] [2] [3] Recent studies have found that klotho, a transmembrane protein, is actively involved in regulation of mineral ion metabolism by affecting the functionality of ion channels and cotransporter proteins in the kidney. 4, 5 The in vivo importance of klotho in regulation of mineral ion metabolism is further evident in klotho-knockout mice because these mice have severely impaired mineral ion homeostasis. 5, 6 Clinical Perspective on p 590
The klotho Ϫ/Ϫ mice develop severe hyperphosphatemia by 3 weeks of age and remain hyperphosphatemic throughout their life. 7, 8 The hyperphosphatemia in klotho Ϫ/Ϫ mice is associated with increased renal expression of the NaPi2a cotransporter protein in the proximal tubular epithelial cells. 3, 7, 9 To assess the significance of increased renal expression of NaPi2a in soft-tissue anomalies and vascular calcification in klotho Ϫ/Ϫ mice, we have generated a new mouse model by genetically ablating both the klotho and the NaPi2a genes.
Hyperphosphatemia and reduced serum levels of 1,25-dihydroxyvitamin D are the major biochemical changes detected in patients with chronic kidney disease (CKD). The current treatment approach of reducing serum phosphate levels and providing vitamin D analogs in patients with CKD often poses a dilemma because studies have linked vitamin D treatment to subsequent vascular calcification. Importantly, Ϸ50% of mortalities in patients with CKD undergoing dialysis treatment are due to the cardiovascular complication of vascular calcification. Our current study provides the in vivo beneficial effects of reducing serum phosphate levels on preventing vascular calcification, even in the presence of extremely high serum 1,25-dihydroxyvitamin D levels.
Methods

Generation of Double-Mutant Mice
We have crossbred heterozygous klotho mutants (Lexicon Genetics; Mutant Mouse Regional Resource Centers, University of California, Davis, Calif) with heterozygous NaPi2a mutants to obtain compound heterozygous animals, which were then interbred to generate the desired double-homozygous mutants (klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ ). 7,9 -11 Routine polymerase chain reaction was used to identify the genotypes of various mice (supplemental Figure I) . All studies performed were approved by the institutional animal care and use committee at Harvard Medical School (Boston, Mass).
Gross Phenotype and Body Weight
The total body weight of each of wild-type, klotho Ϫ/Ϫ , NaPi2a Ϫ/Ϫ , and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice was taken every week starting at 3 weeks of age until 20 weeks of age. The maximum survival of klotho Ϫ/Ϫ mice was around 15 weeks.
Biochemical Measurements
Blood was obtained by cheek-pouch bleeding of wild-type, klotho Ϫ/Ϫ , NaPi2a Ϫ/Ϫ , and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice. Serum was isolated by centrifugation at 3000g for 10 minutes and stored at Ϫ80°C. Serum and urinary phosphorus and calcium were determined by colorimetric measurements using the Stanbio Phosphorus 
/NaPi2a
Ϫ/Ϫ mice. Gross phenotype of wild-type (WT), klotho mice using a commercial kit (Immunodiagnostic Systems Ltd, Fountain Hills, Ariz). The serum level of parathyroid hormone (PTH) was measured using a commercial kit (Immutopics, Inc, San Clemente, Calif). The serum level of Fgf23 was measured with ELISA using a commercial kit (Kainos Laboratories, Tokyo, Japan), as described in a previous publication. 7
Histological Analyses
Soft tissues obtained from wild-type, klotho Ϫ/Ϫ , NaPi2a Ϫ/Ϫ , and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice at 9 to 12 weeks were fixed with 4% paraformaldehyde, 10% buffered formalin, or Carnoy's solution and were subsequently embedded in paraffin. Four-to 6-m paraffin sections of various tissues were mounted on SuperFrost Plus slides. The sections were then routinely stained with hematoxylin and eosin and von Kossa. 13, 14 Histological changes were observed by light microscopy.
Calcification Analyses
To determine the effects of hyperphosphatemia on soft-tissue and vascular calcification in klotho Ϫ/Ϫ mice, sections were prepared from the heart, lung, kidney, liver, spleen, aorta, and gastrointestinal tract and were stained with von Kossa to visualize mineralized tissues by light microscopy. The von Kossa-stained sections of klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were compared with similarly stained sections from wild-type, klotho Ϫ/Ϫ , and NaPi2a Ϫ/Ϫ mice. The von Kossa staining procedure was detailed in an earlier publication. 15 
Immunofluorescence Staining
Immunostaining was performed as described previously. 16 -18 In brief, kidneys obtained from wild-type and klotho Ϫ/Ϫ mice were embedded in Optimal Cutting Temperature (OCT) compound and stored at Ϫ80°C. Frozen sections were incubated in a blocking solution for 30 minutes and then with polyclonal anti-NaPi2a antibody (dilution 1:100; Alpha Diagnostic, San Antonio, Tex) at 4°C for overnight. The slides were washed with PBS and incubated with fluorescein isothiocyanate-labeled anti-rabbit secondary antibody (dilution, 1:100) for 30 minutes. After washing with PBS, cover slips were placed on slides using 4,6-diamidino-2-phenylindole -containing mounting media. The expression of NaPi2a was visualized using an immunofluorescence microscopy. Rabbit serum, in place of primary antibody, was used as a negative control. Kidney sections prepared from NaPi2a Ϫ/Ϫ mice were simultaneously stained for NaPi2a and used as additional negative control.
Quantitative Real-Time Polymerase Chain Reaction
Total RNA isolated from the 3 or more kidneys and aortas of wild-type, klotho Ϫ/Ϫ , NaPi2a Ϫ/Ϫ , and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice was used to detect the relative expression of Ennp-1, ANK, Pit-1, and RUNX2 mRNA, as described previously. 12, 19 Real-time polymerase chain reaction was performed in duplicate. The quantity of mRNA was calculated by normalizing the threshold cycle value of Ennp-1, ANK, Pit-1, or RUNX2 to the threshold cycle value of the housekeeping gene GAPDH. The sequences of the primers used to detect expression patterns of various genes are reported in our earlier publications. 7 
Statistical Analysis
Statistically significant differences between groups were evaluated either by the Student t test or by the Mann-Whitney U test for a comparison between 2 groups. All values were expressed as meanϮSE. A P value Ͻ0.05 was considered to be statistically significant. All analyses were performed using Microsoft Excel.
Results and Discussion
The identification of specific phosphate transporters has enhanced our understanding of the regulation of renal and intestinal phosphate handling. The type II family of NaPi Ϫ/Ϫ mice (nϭ5; 58.3Ϯ28 pg/mL). Serum PTH levels are low and undetectable in both klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ (DKO) and NaPi2a Ϫ/Ϫ mice, respectively. We also measured serum PTH levels in 1-␣ hydroxylase knockout mice as a positive control and found significantly increased levels (nϭ4; 2443.4Ϯ610 pg/mL), compared with the controls. As for serum 1,25(OH) 2 Ϫ/Ϫ mice (nϭ6; 7107 pg/mL) compared with wild-type (WT) mice (nϭ9; 176 pg/mL). Similarly, increased FGF23 serum levels are also noted in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ (DKO) mice (nϭ7; 7440 pg/mL). The serum FGF23 levels is extremely low (nϭ6; 53 pg/mL) in NaPi2a Ϫ/Ϫ mice. Data presented after adjusting dilution factors (**PϽ0.001, versus WT; ##PϽ0.001, versus NaPi2a).
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cotransporters consists of 3 highly homologous isoforms: type IIa (NaPi2a) and type IIc (NaPi2c), which are mostly expressed in the brush-border membrane of the renal proximal tubules, 20 and type IIb (NaPi2b), which is expressed in the epithelial cells of the small intestine and is thought to be involved in intestinal phosphate absorption. Renal phosphate transport through NaPi2a is an important mechanism for maintaining systemic phosphate balance.
To determine the expression pattern of NaPi2a in klotho Ϫ/Ϫ mice, we stained kidney sections from wild-type and klotho Ϫ/Ϫ mice with NaPi2a antibody. Compared with wildtype mice, increased expression of NaPi2a protein, in the luminal side of the proximal tubules, was noted in sections prepared from klotho Ϫ/Ϫ mice (supplemental Figure II) . It is presumed that increased expression of NaPi2a is associated with increased renal reuptake of phosphate, 21 resulting in hyperphosphatemia and extensive vascular calcification in klotho Ϫ/Ϫ mice (supplemental Figure III) . To test this hypothesis, we generated klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice and compared their physical, morphological, and biochemical phenotype with klotho Ϫ/Ϫ mice. As mentioned, genetic deletion of klotho results in hyperphosphatemia. 8, 9 To determine whether hyperphosphatemia in klotho Ϫ/Ϫ mice is a NaPi2a-dependent process, we generated a new mouse model that is deficient in both klotho and NaPi2a genes (klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ ) by interbreeding heterozygous klotho mice with heterozygous NaPi2a mice. The klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were viable and larger in size to klotho Ϫ/Ϫ mice. At birth, klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were indistinguishable from their littermates of other genotypes. At 3 weeks of age, klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were slightly larger in size than klotho Ϫ/Ϫ mice (12.8Ϯ0.5 g versus 10.4Ϯ0.5 g) but smaller than wild-type mice (16.0Ϯ0.5 g). Double-knockout mice were similar in size to NaPi2a Ϫ/Ϫ animals (13.4Ϯ0.27 g). At 9 weeks of age, klotho Ϫ/Ϫ / NaPi2a Ϫ/Ϫ mice were still smaller than their wild-type littermates (20.2Ϯ0.85 g versus 28.8Ϯ1.1 g), but their body weight was significantly higher than that of klotho Ϫ/Ϫ mice (11.3Ϯ0.9 g). At 9 weeks of age, the average body weight of NaPi2a Ϫ/Ϫ mice was 25.7Ϯ0.76 g (Figure 1 ). Furthermore, klotho Ϫ/Ϫ mice had a maximum survival of around 15 weeks, whereas all the klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were capable of survival beyond 15 weeks and were alive until 20 weeks of observation period.
Next, we measured serum phosphate and calcium levels in 3-, 6-, and 9-week-old wild-type, klotho Ϫ/Ϫ , NaPi2a Ϫ/Ϫ , and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice. The double-knockout mice were slightly hypophosphatemic by 6 weeks of age (7.2Ϯ0.41 mg/dL, nϭ10) compared with wild-type mice (8.5Ϯ0.69 mg/dL, nϭ5). The low serum phosphate levels were also noted in age-matched NaPi2a Ϫ/Ϫ mice (4.6Ϯ0.14 mg/dL, nϭ10). Serum phosphate levels were high in klotho Ϫ/Ϫ mice (12.1Ϯ0.64 mg/dL, nϭ11; Figure 2 ). Significant reduction of serum phosphate levels was also noted in 9-week-old doubleknockout mice compared with klotho Ϫ/Ϫ mice. Collectively, these findings suggest that inactivation of NaPi2a function can reverse hyperphosphatemia to hypophosphatemia or normophosphatemia at 3, 6, and 9 weeks of age.
Serum calcium levels were higher in the klotho Ϫ/Ϫ mice at around 6 weeks of age, as also noted in both NaPi2a Ϫ/Ϫ and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice (Figure 2 ). At around 6 weeks of age, serum calcium in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice (11.4Ϯ0.44 mg/dL, nϭ12) was significantly higher than in wild-type mice (7.6Ϯ0.46 mg/dL, nϭ6). The higher serum levels of calcium were also noted in klotho Ϫ/Ϫ mice (9.8Ϯ0.34 mg/dL, nϭ10) and NaPi2a Ϫ/Ϫ mice (10.0Ϯ0.12 mg/dL, nϭ10) of similar age (Figure 2) . Despite reversal of serum phosphate level from severe hyperphosphatemia to mild hypophosphatemia or normophosphatemia in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice, the serum 1,25(OH) 2 D 3 levels in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice were extremely high. Statistically significant increased serum levels of 1,25(OH) 2 D 3 were also detected in klotho Ϫ/Ϫ and NaPi2a Ϫ/Ϫ mice ( Figure 3 ). In contrast to 1,25(OH) 2 D 3 , serum PTH levels were markedly reduced in klotho Ϫ/Ϫ and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice ( Figure 3) ; serum PTH was also extremely low in NaPi2a Ϫ/Ϫ mice. Of relevance, compared with the control (176 pg/mL), serum FGF23 levels were extremely high in the klotho Ϫ/Ϫ mice (7107 pg/mL) at 6 weeks of age. 22 Markedly increased serum levels of FGF23 were also noted in the klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice (7440 pg/mL); the serum FGF23 levels were low in NaPi2a Ϫ/Ϫ mice (53 pg/mL; Figure 4) .
The major finding of our in vivo genetic manipulation studies is that NaPi2a regulates systemic phosphate homeostasis in klotho Ϫ/Ϫ mouse. Inactivation of the NaPi2a gene from klotho Ϫ/Ϫ mice reversed severe hyperphosphatemia to hypophosphatemia or normophosphatemia, despite significantly higher serum levels of calcium and 1,25(OH) 2 D 3 .
We then examined the effects of reducing serum phosphate from klotho Ϫ/Ϫ mice on vascular and soft-tissue calcification. Extensive vascular and soft-tissue calcifications were present in the heart, lung, kidney, aorta, and other organs in klotho Ϫ/Ϫ mice, as determined by von Kossa staining (Supplemental Figure III) . The extensive calcification observed in klotho Ϫ/Ϫ mice by 6 weeks was significantly reduced or eliminated in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice, even at 12 weeks of age ( Figures  5 and 6 ). These results indicate that high serum phosphate is an important determinant of calcification and that lowering Ϫ/Ϫ mice showing extensive calcifications in the lung parenchyma and vessel wall of klotho Ϫ/Ϫ mice. Inactivation of NaPi2a from klotho Ϫ/Ϫ mice reduced such calcification from DKO mice. Similarly, vascular calcification is also noted in heart (lower 4 panels) of klotho Ϫ/Ϫ mice but is absent in DKO mice (von Kossa staining; lung ϫ20, heart ϫ10).
serum phosphate levels can reduce or eliminate calcification, even in the presence of higher serum calcium and 1,25(OH) 2 D 3 levels (Figure 3) .
Lowering serum phosphate levels in klotho Ϫ/Ϫ mice significantly reduced soft-tissue anomalies, helped restore fertility, and markedly reduced extensive soft-tissue and vascular calcifications in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice (Table) . These results suggest that the phenotypes of klotho Ϫ/Ϫ mice are mostly derived from high serum phosphate levels. Despite significantly high serum levels of calcium and 1,25(OH) 2 D 3 , the opposing phenotypes of klotho Ϫ/Ϫ and klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice suggest that such dissimilarities are due to phosphate toxicity. Our results provide compelling genetic evidence of the in vivo importance of NaPi2a in the regulation of systemic phosphate homeostasis in klotho Ϫ/Ϫ mice and show that abnormal regulation of NaPi2a cotransporters can lead to phosphate toxicity to induce severe soft-tissue anomalies, including general tissue atrophy and reduction of skeletal muscle mass. Of relevance, hyperphosphatemia and severe muscle wasting are common clinical problems encountered in patients with CKD.
Extensive vascular and soft-tissue calcifications were widely present in the lung, kidney, aorta, and other organs in klotho Ϫ/Ϫ mice, as detected by von Kossa staining ( Figure 5, Supplemental Figure III) . The extensive calcification noted in klotho Ϫ/Ϫ mice by 6 weeks of age was completely eliminated in klotho Ϫ/Ϫ /NaPi2a Ϫ/Ϫ mice and was not detected even in 12-week-old double-mutant mice. These results indicated that high serum phosphate is an important determinant of calcification and that lowering serum phosphate levels can reduce or eliminate calcification, even in the presence of higher serum 1,25(OH) 2 D 3 levels ( Figure 3) .
Phosphate retention and subsequent hyperphosphatemia, together with reduced circulating levels of 1,25-dihydroxyvitamin D, are the major biochemical changes detected in patients with CKD. 23 Coronary calcification is the single most important pathological condition that influences the mortality of patients with CKD undergoing dialysis treatment. 24 Hyperphosphatemia is believed to be an important risk factor for such cardiovascular calcification. 25 The current approach of reducing serum phosphate levels and correcting vitamin D insufficiency or deficiency in patients with CKD often poses a dilemma because high doses of vitamin D or analog treatment are believed to affect the subsequent vascular calcification process. Our in vivo genetic manipulation study suggests that minimizing phosphate toxicity can reduce vascular calcification, even in the presence of extremely high serum 1,25-dihydroxyvitamin D and calcium levels. One limitation of animal study is that the mechanisms of human vascular diseases in renal insufficiency may be different from those in vascular lesions in klotho Ϫ/Ϫ mice, and established medial and atherosclerotic lesions may persist even after molecular manipulations because advanced stages of calcification may not be reversible. We believe that lowering serum phosphate levels can delay the progression of vascular lesions but may not always reverse the established lesions. Hyperphosphatemia in klotho Ϫ/Ϫ mice is associated with extensive soft-tissue calcification ( Figure 5 , Supplemental Figure III) . 7, 9, 22 Imbalance between phosphate and pyrophosphate usually determines the ectopic calcification process. 26, 27 We have found that the expression of Ennp-1 (pyrophosphate generator) and ANK (pyrophosphate transporter) is slightly increased in the kidneys and aortas of klotho Ϫ/Ϫ mice and that such increase might be a compensatory response in these mutant mice (supplemental Figures IV and V) . Because increase of pyrophosphate-regulating molecules cannot suppress calcification process, it seems likely that extensive calcification in klotho Ϫ/Ϫ mice is primarily associated with high serum phosphate levels.
In summary, the phenotypes of klotho Ϫ/Ϫ /NaPi2a
Ϫ/Ϫ mice suggest that (1) increased NaPi2a activity is the main cause for the severe hyperphosphatemia and ectopic calcification observed in klotho Ϫ/Ϫ mice; and (2) NaPi2a-mediated renal phosphate homeostasis is independent of serum 1,25(OH) 2 D 3 levels in mice deficient for klotho. Notably, lowering phosphate burden, by reducing serum phosphate levels, can modulate vascular and soft-tissue calcification, despite the presence of extremely high serum 1,25(OH) 2 D 3 levels. These results provide compelling genetic evidence of the importance of NaPi2a in regulating renal phosphate homeostasis in klotho Ϫ/Ϫ mice, and more importantly, suggest that reducing "phosphate toxicity" should be the single most important therapeutic priority in minimizing the risk of vascular calcification and eventual disease progression. 23,28 -30 
